Asia Green Biotechnology Corp. Reports Delay in Annual Financial Filings

Asia Green Biotechnology Corp. announced a delay in filing its annual financial statements and management discussion due to issues with its former auditor. The required documents, initially due April 29, 2024, are now expected by May 27, 2024. The delay stems from an investigation into the auditor's unrelated activities, disrupting their ability to complete required audits for Asia Green.

In response, Asia Green has engaged new auditors and applied for a Management Cease Trade Order (MCTO) with the Alberta Securities Commission to prevent management trading until filings are completed. The company has assured compliance with alternative information guidelines during this period and has implemented an insider trading black-out policy. Asia Green remains free from insolvency proceedings, ensuring no major business developments besides those previously reported.